AXON
Price
$417.19
Change
+$8.77 (+2.15%)
Updated
Oct 15 closing price
Capitalization
34.51B
25 days until earnings call
Intraday BUY SELL Signals
BMRN
Price
$56.05
Change
+$0.91 (+1.65%)
Updated
Oct 15 closing price
Capitalization
11.51B
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AXON vs BMRN

AXON vs BMRN Comparison Chart in %
View a ticker or compare two or three
VS
AXON vs. BMRN commentary
Oct 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and BMRN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AXON with price predictions
Oct 15, 2026

AXON in -1.45% downward trend, falling for three consecutive days on October 14, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where AXON declined for three days, in 201 of 288 cases, the price declined further within the following month. The odds of a continued downward trend are 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for AXON entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AXON's RSI Oscillator exited the oversold zone, 21 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 56 cases where AXON's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for AXON just turned positive on October 06, 2026. Looking at past instances where AXON's MACD turned positive, the stock continued to rise in 25 of 39 cases over the following month. The odds of a continued upward trend are 64%.

Following a +4.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 276 of 371 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.390) is normal, around the industry mean (6.305). AXON has a moderately high P/E Ratio (176.979) as compared to the industry average of (58.116). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.330).

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

A.I.Advisor
a Summary for BMRN with price predictions
Oct 15, 2026

BMRN in downward trend: price dove below 50-day moving average on September 22, 2026

BMRN moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend. In 36 of 49 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMRN as a result. In 55 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.

The 10-day moving average for BMRN crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

The Aroon Indicator for BMRN entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMRN's RSI Indicator exited the oversold zone, 20 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMRN advanced for three days, in 166 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

BMRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. BMRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.821) is normal, around the industry mean (26.782). P/E Ratio (160.703) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.348) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (3.727) is also within normal values, averaging (437.542).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AXON vs BMRN: Fundamental Ratings
AXON
BMRN
OUTLOOK RATING
1..100
6659
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
8189
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
372
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXON's Valuation (87) in the Biotechnology industry is in the same range as BMRN (93). This means that AXON’s stock grew similarly to BMRN’s over the last 12 months.

AXON's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as BMRN (100). This means that AXON’s stock grew similarly to BMRN’s over the last 12 months.

AXON's SMR Rating (81) in the Biotechnology industry is in the same range as BMRN (89). This means that AXON’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's Price Growth Rating (61) in the Biotechnology industry is in the same range as AXON (64). This means that BMRN’s stock grew similarly to AXON’s over the last 12 months.

BMRN's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for AXON (37). This means that BMRN’s stock grew somewhat faster than AXON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONBMRN
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
65%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 1 day ago
59%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 7 days ago
60%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
65%
COMPARISON
Comparison
Oct 16, 2026
Stock price -- (AXON: $417.19 vs. BMRN: $56.05)
Brand notoriety: AXON and BMRN are both not notable
AXON represents the Aerospace & Defense, while BMRN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 73% vs. BMRN: 133%
Market capitalization -- AXON: $34.51B vs. BMRN: $11.51B
AXON [@Aerospace & Defense] is valued at $34.51B. BMRN’s [@Biotechnology] market capitalization is $11.51B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $4.49 to $1.92T. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Aerospace & Defense] industry is $38.94B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 0 FA rating(s) are green while BMRN’s FA Score has 1 green FA rating(s).

  • AXON’s FA Score: 0 green, 5 red.
  • BMRN’s FA Score: 1 green, 4 red.
According to our system of comparison, both AXON and BMRN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while BMRN’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 2 bearish.
  • BMRN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AXON is a better buy in the short-term than BMRN.

Price Growth

AXON (@Aerospace & Defense) experienced а -0.03% price change this week, while BMRN (@Biotechnology) price change was +2.11% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -5.75%. For the same industry, the average monthly price growth was -12.43%, and the average quarterly price growth was -20.67%.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.57%. For the same industry, the average monthly price growth was -12.13%, and the average quarterly price growth was -18.10%.

Reported Earning Dates

AXON is expected to report earnings on Nov 10, 2026.

BMRN is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Aerospace & Defense (-5.75% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-5.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AXON
Daily Signal:
Gain/Loss:
BMRN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
CVP.X0.0026580.000066
+2.56%
PowerPool cryptocurrency
PUNDIX.X0.1048320.000344
+0.33%
Pundi X (New) cryptocurrency
UTK.X0.011789N/A
N/A
Utrust cryptocurrency
DOT.X1.145846-0.000528
-0.05%
Polkadot cryptocurrency
FUN.X0.008157-0.000645
-7.32%
FUNToken cryptocurrency